DNMT1 and hepatocellular carcinoma: It has been documented that in the regulation of AChE by the DNMT1, the use of 5-Aza-2’-deoxycytidine, a DNMT1 inhibitor, restores the levels of AChE content downregulated in HCC cells [107].